tornetis 25 mg/1 tableta tableta
novartis ba d.o.o. - sildenafil - tableta - 25 mg/1 tableta - 1 tableta sadrži: 25 mg sildenafila (u obliku sildenafil citrata)
tornetis 50 mg/1 tableta tableta
novartis ba d.o.o. - sildenafil - tableta - 50 mg/1 tableta - 1 tableta sadrži: 50 mg sildenafila (u obliku sildenafil citrata)
tornetis 100 mg/1 tableta tableta
novartis ba d.o.o. - sildenafil - tableta - 100 mg/1 tableta - 1 tableta sadrži: 100 mg sildenafila (u obliku sildenafil citrata)
microgynon 30 0.15 mg/1 tableta+ 0.03 mg/1 tableta obložena tableta
bayer d.o.o. sarajevo - etinilestradiol, levonorgestrel - obložena tableta - 0.15 mg/1 tableta+ 0.03 mg/1 tableta - 1 obložena tableta sadrži: 0,15 mg levonorgestrela i 0,03 mg etinilestradiola
triquilar 50 µg/1 tableta+ 30 µg/1 tableta+ 75 µg/1 tableta+ 40 µg/1 tableta+ 125 µg/1 tableta+ 30 µg/1 tableta obložena tableta
bayer d.o.o. sarajevo - etinilestradiol, levonorgestrel - obložena tableta - 50 µg/1 tableta+ 30 µg/1 tableta+ 75 µg/1 tableta+ 40 µg/1 tableta+ 125 µg/1 tableta+ 30 µg/1 tableta - 1 obložena tableta sadrži: 50 mcg levonorgestre + etinilestradiol 30 mcg (crvenosmeđa) 75 mcg levonorgestre + etinilestradiol 40 mcg (bijela) 125 mcg levonorgestre + etinilestradiol 30 mcg (tamnožuta)
letrox 100 100 µg/1 tableta tableta
berlin chemie / menarini bh d.o.o. sarajevo - levotiroksinnatrijum - tableta - 100 µg/1 tableta - 1 tableta sadrži: 100 mcg levotiroksinnatrijum
letrox 150 150 µg/1 tableta tableta
berlin chemie / menarini bh d.o.o. sarajevo - levotiroksinnatrijum - tableta - 150 µg/1 tableta - 1 tableta sadrži: 150 mcg levotiroksinnatrijum
insuman
sanofi-aventis deutschland gmbh - insulin human - Šećerna bolest - lijekovi koji se koriste u dijabetesu - diabetes mellitus gdje je potrebno liječenje inzulinom. insuman rapid je pogodan za liječenje hiperglikemijsku komu i ketoacidoza, kao i za postizanje unaprijed, intra - i postoperativna stabilizacija u bolesnika sa šećernom bolešću.
blincyto
amgen europe b.v. - blinatumomab - prekursorska stanica limfoblastične leukemije-limfom - antineoplastična sredstva - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.
omnipaque 647 mg/1 ml otopina za injekciju
amicus pharma d.o.o. - joheksol - otopina za injekciju - 647 mg/1 ml - 1 ml otopine za injekciju sadrži:647 mg joheksola (što odgovara 300 mg joda)